These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15035418)

  • 1. [Allergy counseling in the doctor's office. From allergy to asthma is only a small step].
    Barczok M
    MMW Fortschr Med; 2004 Jan; 146(5):42-3. PubMed ID: 15035418
    [No Abstract]   [Full Text] [Related]  

  • 2. [For the family physician allergy season is all year long. Strategies against running noses].
    Wiedemann B
    MMW Fortschr Med; 2002 Nov; 144(45):4-6. PubMed ID: 12534052
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
    Dahl R; Stender A; Rak S
    Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S; Spicuzza L; La Rosa M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
    [No Abstract]   [Full Text] [Related]  

  • 5. [House dust mite allergy: myths and realities].
    Bouton C; Ducommun J
    Rev Med Suisse; 2009 Apr; 5(199):832-6. PubMed ID: 19441749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
    Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A
    J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pollen-induced allergy. Programming and monitoring of specific immunotherapy].
    Obtułowicz K
    Folia Med Cracov; 1988; 29(1-2):21-48. PubMed ID: 3255656
    [No Abstract]   [Full Text] [Related]  

  • 9. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 10. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
    Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
    Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis.
    Andrews CP; Ratner PH; Ehler BR; Brooks EG; Pollock BH; Ramirez DA; Jacobs RL
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):9-13. PubMed ID: 23806453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study.
    Giovannini M; Braccioni F; Sella G; Contoli M; Perri G; Frati F; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):69-71. PubMed ID: 15859367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of specific prevention of pollinoses and dust-induced bronchial asthma].
    Poroshina IuA; Rybchinskaia LM; Chervinskaia TA; Titova SM
    Ter Arkh; 1981; 53(1):94-8. PubMed ID: 7013142
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against allergies yields good symptom relief].
    Hedlin G; Arvidsson M
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1938-41. PubMed ID: 18681376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicenter controlled trial of desensitization treatment of pollen-induced hay fever and asthma with pollinex vaccine].
    Adamek-Guzik T; Szczeklik A; Wołoszyński J
    Pol Tyg Lek; 1979 Jul; 34(28):1111-3. PubMed ID: 390511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.